Stay updated on Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial
Sign up to get notified when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.

Latest updates to the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, reflecting a refreshed build of the page content.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page revision label in the footer was updated from v3.5.0 to v3.5.3, reflecting a ClinicalTrials.gov site version change rather than any modification to the study record content.SummaryDifference0.0%

- Check69 days agoChange Detected- The page now shows Revision: v3.5.0 and the previous Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision note updated from v3.4.2 to v3.4.3 on the site.SummaryDifference0.0%

- Check105 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check112 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.